Marcos M. Alvarez

Marcos M. Alvarez

Auto-generated profile, based on publicly available information

Marcos M. Alvarez

Department of Chemistry, Los Angeles City College, 855 N Vermont Ave, Los Angeles, California 90029, United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2018 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
PLPriscilla Lopez
Priscilla Lopez
HLHumberto H Lara
Humberto H Lara
SMSean M. Mullins
Sean M. Mullins
DBDavid M. Black
David M. Black
HRHeidi M. Ramsower
Heidi M. Ramsower
RWRobert L Whetten
Robert L Whetten

8 June 2016 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
MAMarcos M. Alvarez
Marcos M. Alvarez
JCJenny Chen
Jenny Chen
GPGermán Plascencia-Villa
Germán Plascencia-Villa
DBDavid M. Black
David M. Black
WGWendell P. Griffith
Wendell P. Griffith
RWRobert L Whetten
Robert L Whetten

12 July 2019 in Langmuir
Verified
Journal Article
Closed access
MHMohammad Hoque
Mohammad Hoque
KMKathryn M. Mayer
Kathryn M. Mayer
Arturo PonceArturo Ponce
Arturo Ponce
MAM. M. Alvarez
M. M. Alvarez
RWRobert L Whetten
Robert L Whetten

13 December 2019 in ACS Omega
Verified
Journal Article
Open access
HLHumberto H Lara
Humberto H Lara
DBDavid M. Black
David M. Black
CMChristine Moon
Christine Moon
EOElizabeth Orr
Elizabeth Orr
PLPriscilla Lopez
Priscilla Lopez
RWRobert L Whetten
Robert L Whetten
Many antibiotic resistances to penicillin have been reported, making them obsolete against multiresistant bacteria. Because penicillins act by inhibiting cell wall production while silver particles disrupt the cell wall directly, a synergetic effect is anticipated when both modes of action are incorporated into a chimera cluster. To test this hypothesis, the lipoate ligands (LA) of a silver cluster (Ag29) of known composition (Ag29LA12)[3−] were covalently conjugated to 6-aminopenicillanic acid, a molecule with a β-lactam backbone. Indeed, the partially conjugated cluster inhibited an Staphylococcus aureus biofilm, in a dose–response manner, with a half-maximal inhibitory concentration IC50 of 2.3 μM, an improvement over 60 times relative to the unconjugated cluster (IC50 = 140 μM). An enhancement of several orders of magnitude over 6-APA alone (unconjugated) was calculated (IC50 = 10 000 μM). Cell wall damage is documented via scanning electron microscopy. A synergistic effect of the conjugate was calculated by the combination index method described by Chou–Talalay. This hybrid nanoantibiotic opens a new front against multidrug-resistant pathogens.